PROLIFERATIVE VITREO-RETINOPATHY

Clinical trials for PROLIFERATIVE VITREO-RETINOPATHY explained in plain language.

Never miss a new study

Get alerted when new PROLIFERATIVE VITREO-RETINOPATHY trials appear

Sign up with your email to follow new studies for PROLIFERATIVE VITREO-RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Chemo drug injected into eyes to stop scarring and save sight

Disease control Not yet recruiting

This early-stage trial is testing if a drug called topotecan, injected into the eye during and after surgery, can help prevent a serious complication called proliferative vitreoretinopathy (PVR). PVR causes scarring that can make retinal detachment surgery fail. The study will co…

Matched conditions: PROLIFERATIVE VITREO-RETINOPATHY

Phase: PHASE1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

PROLIFERATIVE VITREO-RETINOPATHY

Get alerted when new PROLIFERATIVE VITREO-RETINOPATHY trials appear

Chemo drug injected into eyes to stop scarring and save sight